Abigail Shockley

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

End Stage Renal Disease

Ejection Fraction

Multiple Myeloma

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Bone marrow transplantation

This page only lists publications with an associated author ORCID identifier.

Publications

James A Davis, Abigail Shockley, Ashley E Glode
Newly approved anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory diffuse large B-cell lymphoma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 28 (3) (2022)
Hamza Hashmi, Abigail Shockley, James A Davis
'Save the day with a Stem Cell Rescue': Use of autologous hematopoietic stem cell boost for hematopoietic recovery after CAR T cell therapy. Bone marrow transplantation 57 (3) (2022)
Abigail Shockley, James A Davis, Kelly J Gaffney, Deidra Smith, Erin Weeda, Hamza Hashmi
Safety and tolerability of lenalidomide maintenance dosing in patients with multiple myeloma post-autologous stem cell transplant. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 28 (7) (2022)
James A Davis, Abigail Shockley, Hamza Hashmi
The emergence of b-cell maturation antigen (BCMA) targeting immunotherapy in multiple myeloma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 28 (4) (2022)